June 30th, 1999
Paladin Issues Options under its Stock Option Plan
Paladin is pleased to announce that it has issued 75,236 share purchase options to Officers and Employees of Paladin. These options shall have a strike price of $4.30 per share and shall vest 20% per year for the next 5 years. This granting of options is consistent with Paladin’s strategy of attracting and retaining the finest people and in motivating them to advance Paladin’s corporate success.
Paladin’s mission is to understand and serve the needs of Canadian health-care professionals in niche therapeutic areas through the development, licensing and commercialization of innovative products.Paladin Labs Inc. is a public company whose shares trade on the Vancouver Stock Exchange under the symbol PLB.
About Paladin Labs Inc.
Paladin Labs, headquartered in Montreal, Quebec is a Canadian developer, marketer and distributor of innovative pharmaceuticals, currently offering products in urology, dermatology, rheumatology and other specialty markets. For more information about Paladin, please visit the Paladin Web Site at www.paladin-labs.com or send e-mail to ir@paladin-labs.com.
This news release may contain forward-looking statements or predictions. These statements represent our judgement as of this date and are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed in such forward-looking statements Potential risks and uncertainties include, without limitation, those associated with product development, clinical trials, future revenues and profitability, and obtaining marketing approval. These documents contain and identify important factors that could cause the actual results to differ materially from those contained in the projections or forward-looking statements.
PALADIN LABS INC.
For more information:
Paladin Labs Inc.